证券记录 · 已归档季度
REPL
Replimune Group, Inc. · Healthcare · Biotechnology
13被追踪持有人
0Δ持有人
20.78M持有股份
$202.64M报告持仓市值
+0新建仓位
−0清仓
动量输入（同类管理人）： 持有人广度 0.0% · 股份流向 +5.8% · 净新建仓位 0.0% — 公式
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q1 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 75 | +2 | 45.55M | $503.98M | +13 | −11 |
| Q1 2026 | 75 | +4 | 41.32M | $315.89M | +10 | −6 |
| Q4 2025 | 71 | +3 | 45.45M | $441.76M | +3 | — |
| Q3 2025 | 15 | -4 | 32.26M | $135.16M | — | −4 |
| Q2 2025 | 16 | 0 | 29.86M | $277.39M | — | — |
| Q1 2025 | 13 | 0 | 20.78M | $202.64M | — | — |
| Q4 2024 | 13 | +1 | 19.63M | $237.78M | +2 | −1 |
| Q3 2024 | 11 | +1 | 14.48M | $158.71M | +1 | — |
| Q2 2024 | 10 | — | 16.01M | $144.07M | — | — |
持有人 · Q1 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | T. Rowe Price ✦ | 10.85M | -1.0% | $105.83M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 2 | T. Rowe Price ✦ | 10.85M | -1.0% | $105.83M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 3 | Marshall Wace ✦ | 2.49M | +177.6% | $24.25M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 4 | Marshall Wace ✦ | 2.49M | +177.6% | $24.25M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 5 | Marshall Wace ✦ | 2.49M | +177.6% | $24.25M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 6 | State Street Global Advisors ✦ (被动) | 2.40M | +8.8% | $23.38M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 7 | Geode Capital Management ✦ (被动) | 1.67M | +17.0% | $16.31M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 8 | Geode Capital Management ✦ (被动) | 1.67M | +17.0% | $16.31M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 9 | Millennium Management ✦ | 1.22M | +2.8% | $11.93M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 10 | Wellington Management ✦ | 936.36K | -14.6% | $9.13M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 11 | Wellington Management ✦ | 936.36K | -14.6% | $9.13M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 12 | Wellington Management ✦ | 936.36K | -14.6% | $9.13M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 13 | Wellington Management ✦ | 936.36K | -14.6% | $9.13M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 14 | Wellington Management ✦ | 936.36K | -14.6% | $9.13M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 15 | D. E. Shaw & Co. ✦ | 796.58K | -18.1% | $7.77M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 16 | D. E. Shaw & Co. ✦ | 796.58K | -18.1% | $7.77M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 17 | Renaissance Technologies ✦ | 156.24K | -0.5% | $1.52M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 18 | Point72 Asset Management ✦ | 95.98K | -66.2% | $935,776 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 19 | Fisher Asset Management ✦ | 81.95K | +5.5% | $799,002 | 0.0% | ▲ Add | 4 | SEC ↗ |
| 20 | Two Sigma Investments ✦ | 44.40K | -79.1% | $432,929 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 21 | Citadel Advisors ✦ | 22.75K | -83.3% | $221,861 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 22 | AQR Capital Management ✦ | 13.25K | -13.4% | $129,198 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 23 | AQR Capital Management ✦ | 13.25K | -13.4% | $129,198 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 24 | AQR Capital Management ✦ | 13.25K | -13.4% | $129,198 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 25 | AQR Capital Management ✦ | 13.25K | -13.4% | $129,198 | 0.0% | ▼ Trim | 3 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| 本季度无新增被追踪买入方。 |
已清仓
| 本季度无被追踪的退出仓位。 |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 1 持有人, 70.00K 股份, $535 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Aug 17
Hill Emily Luisa
Officer · 9.26K 股 · $132,176
Aug 10
Hill Emily Luisa
Officer · 11.45K 股 · $148,481
Aug 10
Patel Sushil
Officer, Director · 39.34K 股 · $510,253
Aug 10
Schwendenman Andrew
Officer · 7.63K 股 · $98,987
Aug 10
Xynos Konstantinos
Officer · 11.45K 股 · $148,468
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
Aug 14
SC 13G/A — Ridgeback Capital Investments L.P.
Aug 11
SC 13D/A — BAKER BROS. ADVISORS LP
11.8% 占股份类别 · 查看 SEC 原始申报文件 ↗
Aug 10
SC 13G — GOLDMAN SACHS GROUP INC
Aug 07
SC 13G — STATE STREET CORP
Aug 06
SC 13G/A — MONTANOVA CAPITAL, LLC
May 21
SC 13G — Ridgeback Capital Investments L.P.
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q1 2025 ·
方法论 ·
通过API获取此数据